This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subbarao, I.
Right arrow Articles by James, J. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Subbarao, I.
Right arrow Articles by James, J. J.

Original Research and Critical Analysis

Postexposure Immunization and Prophylaxis of Bloodborne Pathogens Following a Traumatic Explosive Event: Preliminary Recommendations

Italo Subbarao, DO, MBA, Ruth Steinbrecher, MPH, Litjen Tan, MS, PhD, Kobi Peleg, PhD, MPH, Jessica Zeiger and James J. James, MD, DrPH, MHA

Background: No definitive guidelines have been established in the United States for postexposure immunization and prophylaxis (PEP) to hepatitis B and C viruses (HBV, HCV) and human immunodeficiency virus (HIV) in the event of a traumatic explosive event.

Methods: The American Medical Association’s Center for Public Health Preparedness and Disaster Response assembled a US-Israeli panel of experts, including representatives from disaster medicine, trauma surgery, occupational health, and infectious disease to determine guidelines for adult and pediatric victims following a traumatic explosive event. The panel reviewed the existing Israeli and United Kingdom protocols, previously published Centers for Disease Control and Prevention guidance on occupational and nonoccupational exposures to HBV, HCV, and HIV, before reaching consensus on preliminary guidelines for the United States.

Results: These guidelines recommend an age-appropriate dose and schedule for HBV PEP for individuals presenting from the scene with nonintact skin or mucous membrane exposure, and they also consider HCV and HIV testing in individuals presenting with possible nonintact skin or mucous membrane exposure. The guidelines do not recommend PEP for individuals presenting from the scene with possible superficial skin exposure.

Conclusions: These recommendations offer PEP guidance for bloodborne pathogens and are limited in scope. These recommendations do not address general wound PEP such as tetanus or the need for antibiotics. It is hoped that these guidelines will fill an urgent gap in preparedness until definitive, comprehensive guidelines from the Centers for Disease Control and Prevention are published.

Key Words: suicide bombing • postexposure immunization and prophylaxis • mass casualty • hepatitis B • hepatitis C • HIV